ClinConnect ClinConnect Logo
Search / Trial NCT06233825

Nutritional Intervention to Enhance Recovery After Arthroscopic Knee Surgery in Adults

Launched by DR. CHRIS MCGLORY, PHD · Jan 29, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Omega 3 Fatty Acids Fish Oil Eicosapentaenoic Acid Docosahexaenoic Acid Skeletal Muscle Anterior Cruciate Ligament Essential Amino Acids Magnetic Resonance Imaging Muscle Protein Synthesis

ClinConnect Summary

This clinical trial is looking at how certain nutritional supplements might help people recover better after knee surgery, specifically for those needing reconstruction of the anterior cruciate ligament (ACL). After such surgery, patients often experience a loss of muscle mass and strength in their legs, especially in the first two weeks of recovery. The study will examine whether taking a combination of essential amino acids (which are building blocks of protein) and omega-3 fatty acids can help reduce this muscle loss compared to a placebo (a non-active treatment).

To participate in the trial, you need to be scheduled for ACL reconstruction surgery in Kingston, Ontario, and have a specific type of graft (patellar or quadriceps tendon). You're not eligible if you have certain health conditions, are allergic to fish, or have been taking fish oil recently. Participants will consume the supplements for four weeks before surgery and two weeks after. Throughout the study, researchers will monitor muscle health and how well participants follow the treatment plan. This trial aims to find out if the nutritional approach is feasible and to gather important information for future studies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed anterior cruciate ligament injury requiring reconstruction surgery
  • Surgery in Kingston, ON
  • Patellar tendon graft, quadriceps tendon graft, or hamstring tendon graft reconstruction procedure
  • Exclusion Criteria:
  • Any muscular, neurological, respiratory, or metabolic disease, subject to investigators' discernment, would negatively affect the subject's ability to comply with the study requirements
  • Any form of cancer currently or in the last 5 years
  • Bleeding disorders or antiplatelet / anticoagulation therapy
  • Currently taking fish oils or within the last 6 months
  • Regular consumption (≥ 2x week) of fish oil or oily fish in the last 6 months
  • Allergy or sensitivity to fish, shellfish or safflower oils
  • Currently taking any form of steroid or within the last 6 months
  • Medical inability to attain magnetic resonance imaging scans
  • Known irregular responses to physical activity (e.g., shortness of breath, chest pain, dizziness, etc.)
  • Surgery scheduled outside of research centre
  • Scheduled surgery date \< 5 weeks away
  • Pregnant or plans to become pregnant within the next 6 months
  • Any current illness that impacts ability to participate in protocols

About Dr. Chris Mcglory, Phd

Dr. Chris McGlory, PhD, is a distinguished clinical trial sponsor specializing in innovative research within the fields of nutrition and exercise physiology. With a robust academic background and extensive experience in conducting clinical studies, Dr. McGlory is committed to advancing scientific knowledge and improving health outcomes through meticulously designed trials. His work focuses on the interplay between dietary interventions and physical performance, aiming to translate findings into practical applications for enhancing human health. Dr. McGlory's dedication to ethical research practices and collaboration with multidisciplinary teams ensures the integrity and success of the clinical studies under his sponsorship.

Locations

Kingston, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Chris McGlory, PhD

Principal Investigator

Queen's University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported